Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00696085 · ClinicalTrials.gov registry record · NA
Fetal Alcohol Damage Prevention Study
A NA study of Substance Abuse and Fetal Alcohol Syndrome, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 612
- Enrollment target
- 1
- Study location
NCT00696085 is a NA study of Substance Abuse and Fetal Alcohol Syndrome that has completed, run by Massachusetts General Hospital. The registered enrollment target is 612 participants, below the 5,249-participant average among 58 other Substance Abuse trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00696085, a NA study of Substance Abuse and Fetal Alcohol Syndrome, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 612 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study was to determine whether a series of blood markers of alcohol use obtained from alcohol using pregnant women could help them to change their behavior.
Conditions Studied
Interventions
- BEHAVIORAL Brief motivational intervention
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 612 participants |
| Start Date | 2004-03 |
| Est. Completion | 2008-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00696085
The ClinicalTrials.gov registry entry for NCT00696085 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 612 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,249-participant average among 58 other Substance Abuse trials with a reported enrollment target (88% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Substance Abuse appearing as the primary indexed condition, and to 1 intervention - of which Brief motivational intervention is the first listed.
NCT00696085 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00696085 about?
NCT00696085 is a clinical study titled "Fetal Alcohol Damage Prevention Study". The goal of this study was to determine whether a series of blood markers of alcohol use obtained from alcohol using pregnant women could help them to change their behavior.
What is the current status of trial NCT00696085?
This trial is currently completed. It is a NA study. The enrollment target is 612 participants. The study started on 2004-03. Estimated completion is 2008-02.
What conditions does trial NCT00696085 study?
This clinical trial studies the following conditions: Substance Abuse, Fetal Alcohol Syndrome.
What interventions are being tested in trial NCT00696085?
The interventions under investigation include: Brief motivational intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00696085?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00696085 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Testing ALERT With GTO in Middle Schools
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
The STop UNhealthy Substance Use Now Trial
RECRUITING · NA
-
The Trans-Led Care Study
RECRUITING · NA
-
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.